Sarcoma: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

  NCT06222203· National Cancer Institute (NCI)· Source

• Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

  NCT07428993· St. Jude Children's Research Hospital· Source

• Natural History Study of Kaposi Sarcoma

  NCT06375122· National Cancer Institute (NCI)· Source

• Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  NCT02390752· National Cancer Institute (NCI)· Source

• Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

  NCT06176989· National Cancer Institute (NCI)· Source

• GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors

  NCT07897968· Universität Münster· Source

• Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

  NCT04222413· National Cancer Institute (NCI)· Source

• Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

  NCT02659930· National Cancer Institute (NCI)· Source

• Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  NCT05711615· National Cancer Institute (NCI)· Source

• A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS

  NCT06008093· AstraZeneca· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• CRISPR-Cas Systems 1
• Gene Expression Profiling 5
• Sequence Analysis, RNA 1
• Proteomics 6
• Mass Spectrometry 2
• Flow Cytometry 46
• Immunohistochemistry 18
• Xenograft Model Antitumor Assays 53
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 23
• Machine Learning 2
• Deep Learning 1
• Cohort Studies 3

• Machine learning-powered discovery of a novel berberine derivative inducing SCD-dependent ferroptosis in osteosarcoma.

  J Transl Med, Nov 2025

• Investigation of berberine and its derivatives in Sars Cov-2 main protease structure by molecular docking, PROTOX-II and ADMET methods: in machine learning and in silico study.

  J Biomol Struct Dyn, Nov 2022

See which targets of this disease your abstract mentions, and go to the people working on them.